简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-04-17 10:04 Boehringer Ingelheim and Lilly Announce an Academic Collaboration with University of Oxford to Investigate the Effects of Empagliflozin in People with Chronic Kidney Disease
2018-04-16 09:40 SpinalCyte Applies with FDA to Expand Human Clinical Trial of CybroCell™ Dermal Fibroblasts as Investigational New Drug (IND)
2018-04-16 09:35 Terns Pharmaceuticals Announces the Addition of Juan Carlos Lopez-Talavera, M.D., Ph.D. and Chuan Shih, Ph.D., as Scientific Advisors
2018-04-12 15:31 Faraday Leads ASIC Industry with Supporting Major Projector Technologies
2018-04-12 14:36 HeartSciences Announces Publication of Clinical Study Results in the Journal of the American College of Cardiology (JACC)
2018-04-12 09:33 Boehringer Ingelheim to invest €65 million in avian vaccines
2018-04-11 22:27 JPT Peptide Technologies Launches The Human Proteome Peptide Catalog
2018-04-10 18:05 Swiss Advanced Vision Launches Active Intraocular Lens Concept with Real-Time Autofocus for Cataract Surgery
2018-04-10 13:58 HeartSciences Showcases MyoVista® Wavelet ECG at 2018 China International Medicinal Equipment Fair (CMEF)
2018-04-09 09:26 Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.
2018-04-09 09:22 LYNC Factory and KINTEX Inked Business Collaboration Agreement to Launch the First-Ever Digital Healthcare Fair in Korea
2018-04-09 09:10 Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors
2018-04-04 18:00 Terns Pharmaceuticals Acquires Global, Exclusive Rights to Develop and Commercialize Three NASH Assets from Lilly
2018-04-04 09:41 ResMed Hires Bobby Ghoshal as First Chief Technology Officer
2018-04-03 14:34 First Patient Treated on Mevion's Next Generation Proton Therapy System
2018-04-03 14:10 MaxiNovel Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation for MAX-40279 for the Treatment of Acute Myeloid Leukemia (AML)
2018-04-02 13:45 PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme
2018-03-30 09:54 Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine1
2018-03-27 09:19 Three Leading Animal Health Companies Join Hands to Launch World-Class Vaccine Joint Venture Targeting Foot-and-Mouth Disease in China
2018-03-26 15:15 Takeda Announces Publication of Final Data from ICLUSIG® (ponatinib) Pivotal Phase 2 PACE Trial in Blood

Business Wire Weibo

Press Releases

Latest Releases